PRODUCTS & INNOVATION
LVAD heart pump recipient Martha Jumpiere offers hope to those living with heart failure.
Oct 23 2019
Sometimes it's the little things that can indicate big problems.
Not being able to catch your breath. Having trouble sleeping. Feeling thirsty all the time.
For Martha Jumpiere, those clues were the initial signs of congestive heart failure, a disease that affects nearly 6 million people in the U.S. alone, according to the Centers for Disease Control and Prevention.
At first, she just assumed she was stressed at work or experiencing a brief dip in her otherwise good health. She didn't consider that she might be struggling with a serious cardiovascular disease. Over time, her health worsened.
"My body was out of whack," said Jumpiere, who lives with her family in North Carolina. "I was just crashing in every way but I kept it to myself for quite some time."
She's not alone. Public awareness of heart failure tends to lag behind its prevalence.
According to a recent survey conducted by Abbott, only 20 percent of respondents could identify the symptoms of heart failure experienced by Martha. The majority of respondents didn't think heart failure would affect them or their family, even though it directly or indirectly affects 2 in 5 Americans.
Starting a New Chapter
For many people, it takes experiencing a crisis to make them realize they need help.
One day, Jumpiere was on the phone with her daughter when she suddenly found herself struggling to breathe. Jumpiere initially thought she was having an anxiety attack but ultimately followed her intuition that something was wrong.
"I think there's a moment in time where you kind of stop," said Trina, Jumpiere's daughter. "For me and my sister, it was just that. We said, 'We have an illness here that we have to figure out and we have to learn as much as we can.' "
After visiting the doctor, Martha learned that she had heart failure and would eventually need a new heart. But like many others on the transplant waitlist, she had to wait for one to come available first, which can take a year or more for most patients, according to the American Journal of Transplantation.
An interim solution was needed, so her care team suggested Abbott's HeartMate 3™ left ventricular assist device (LVAD) until a heart potentially becomes available. The tiny pump helps Martha's heart do the job it has become too weak to do on its own.
Surviving and Moving Forward
With the HeartMate 3, Jumpiere has gotten back to life as an active grandma who plays bingo, dances and bowls. There was recovery time after her LVAD procedure but now she's returned to her routines.
"When I first woke up, I said, 'Dern! I'm connected!' " Jumpiere said, referring to the wires that now attach her to her LVAD battery pack in her fanny pack. "But then again, I said, 'I'm living.' My life changed. I woke up refreshed, feeling like a million bucks. I am a survivor."
Jumpiere likes to add in that last part. She'll always be one.
While she knows there's no cure for heart failure, she's also begun to understand that her condition can be managed successfully and she can still live a fulfilling life.
That's exactly what Jumpiere intends to keep doing. Her only regret is that she didn't open up about her symptoms sooner. Given the severity of heart failure (and of other cardiovascular diseases), telling someone could be all the difference.
"Tell your family," Jumpiere said. "They love you. They're your strength. I'm living even stronger now because I'm surviving — and they're there to watch me and to keep me going."
Individual Experience: This testimonial relates an account of an individual's response[CB1] to the treatment. The patient's account is genuine, typical and documented. However, it does not provide any indication, guide, warranty or guarantee as to the response other persons may have to the treatment. Responses to the treatment discussed can and do vary and are specific to the individual patient.
Indications and Important Safety Information
Brief Summary: Prior to using these devices, please review the Instructions for Use of a complete listing of indications, contraindications, warnings, precautions, potential adverse events and directions for use.
Indications: The HeartMate 3 Left Ventricular Assist System is indicated for providing short- and long-term mechanical circulatory support (e.g., as bridge to transplant or myocardial recovery, or destination therapy) in patients with advanced refractory left ventricular heart failure.
Contraindications: The HeartMate 3 Left Ventricular Assist System is contraindicated for patients who cannot tolerate, or who are allergic to, anticoagulation therapy.
Adverse Events: Adverse events that may be associated with the use of the HeartMate 3 Left Ventricular Assist System are: death, bleeding, cardiac arrhythmia, localized infection, right heart failure, respiratory failure, device malfunctions, driveline infection, renal dysfunction, sepsis, stroke, other neurological event (not stroke-related), hepatic dysfunction, psychiatric episode, venous thromboembolism, hypertension, arterial non-central nervous system (CNS) thromboembolism, pericardial fluid collection, pump pocket or pseudo pocket infection, myocardial infarction, wound dehiscence, hemolysis (not associated with suspected device thrombosis) or pump thrombosis.
With Tech, Bionic Humans Near Reality
What Will the Digital Healthcare Revolution Look Like?
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimized for your specific screen size.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.
The website that you have requested also may not be optimized for your screen size.